(CODX) – Company Press Releases
-
Co-Diagnostics, Inc. Reports Second Quarter 2022 Financial Results
-
/C O R R E C T I O N -- Co-Diagnostics/
-
Co-Diagnostics, Inc. to Participate in Yale University SalivaDirect™ Conference Held July 28-29 in Chicago
-
Co-Diagnostics, Inc. to Announce Expansion of OEM Agreement with Bio Molecular Systems at AACC
-
Co-Diagnostics, Inc. to Host Booth at AACC Held July 24-28 in Chicago
-
Co-Diagnostics, Inc. Announces Shipment of Monkeypox Virus Test
-
Co-Diagnostics, Inc. to Present at 29th International Biodetection Technologies Virtual Conference
-
Co-Diagnostics, Inc. to Present at Sidoti Summer Small Cap Virtual Conference
-
Co-Diagnostics, Inc. to Host Booth at MEDEXPO Africa 2022 in Nairobi, Kenya on June 9-11
-
Co-Diagnostics, Inc. Completes Principal Design of Test for Monkeypox Virus
-
Co-Diagnostics, Inc. to Participate in the H.C. Wainwright 2022 Global Investment Conference on May 23-26
-
Co-Diagnostics Reports Solid First Quarter 2022 Financial Results
-
Co-Diagnostics, Inc. to Host Booth at Medical Fair Brasil 2022 in São Paulo on May 3-6
-
CO-DIAGNOSTICS, INC. ANNOUNCES FIRST QUARTER 2022 EARNINGS RELEASE DATE AND WEBCAST
-
Co-Diagnostics, Inc. to Host Booth at ECCMID 2022 in Lisbon, Portugal on April 23-26
-
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Hepatitis C Viral Load Test
-
Co-Diagnostics Reports Full Year 2021 Financial Results
-
Co-Diagnostics, Inc. Makes Strategic Additions to Scientific Advisory Board
-
Co-Diagnostics, Inc. Announces Authorization of $30 Million Share Repurchase Program
-
CO-DIAGNOSTICS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 EARNINGS RELEASE DATE AND WEBCAST
-
Co-Diagnostics, Inc. to Sponsor and Present at Molecular Med Tri-Con 2022
-
Co-Diagnostics, Inc. to Host Booth at Life Sciences Day on the Hill on February 16 at the Utah State Capital
-
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Hepatitis B Viral Load Test
-
Co-Diagnostics, Inc. to Host Booth at Medlab Middle East 2022 in Dubai on January 24-27
-
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for High-Risk HPV Multiplex Test
-
Co-Diagnostics, Inc. to Participate in the H.C. Wainwright 2022 BioConnect Virtual Conference on January 10-13
-
Co-Diagnostics, Inc. Announces Completion of the Acquisition of all Assets and Intellectual Property Related to At-Home/Point-of-Care Platform
-
Co-Diagnostics, Inc. Signs Agreement to Acquire all Assets and Intellectual Property Related to At-Home/Point-of-Care Platform
-
Creator of COVID-19 and Global Molecular Testing Products Co-Diagnostics, Inc. Launches Retail Investor and Perks Program with TiiCKER
-
Co-Diagnostics JV CoSara Receives Clearance from Indian Regulators for ABC Multiplex Test
-
Co-Diagnostics, Inc. Reports that Suite of COVID-19 Diagnostics Not Affected by Heavily Mutated Omicron Variant
-
Co-Diagnostics, Inc. to Host Booth at MEDICA 2021 Trade Fair in Düsseldorf, Germany
-
Co-Diagnostics Reports Continued Strength in Third Quarter 2021 Financial Results
-
Co-Diagnostics, Inc. Logix Smart™ COVID-19 2-Gene Test Approved for Use in the United Kingdom
-
Co-Diagnostics, Inc. Announces Third Quarter 2021 Earnings Release Date And Webcast
-
Co-Diagnostics JV CoSara Receives Clearance from Indian Regulators for Dengue/Chikungunya Multiplex Test
-
Co-Diagnostics, Inc. to Introduce At Home/Point of Care Device at AACC on Sept 28
-
Co-Diagnostics, Inc. Announces Corporate Rebranding Following Period of Transformative Growth and Expansion
-
Co-Diagnostics, Inc. to Present at ACTC Liquid Biopsy Conference in Kalamata, Greece
-
Co-Diagnostics, Inc. Logix Smart™ ABC Test Authorized for Use in Mexico
-
Co-Diagnostics, Inc. to Present at Sidoti Virtual Investor Conference
-
Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for Chikungunya and Dengue Tests
-
Co-Diagnostics, Inc. CEO to Participate in Panel Discussion with Scott Gottlieb, M.D., at H.C. Wainwright 2021 Annual Global Investor Conference
-
Co-Diagnostics, Inc. SARS-CoV-2 Test Used in New Community Surveillance Method in Italy
-
Co-Diagnostics, Inc. To Present At 13th Next Generation Dx Summit In Washington, D.C.
-
Co-Diagnostics Reports Strong Second Quarter 2021 Financial Results
-
Co-Diagnostics, Inc. Announces Second Quarter 2021 Earnings Release Date And Webcast
-
Co-Diagnostics, Inc. Strengthens Intellectual Property Portfolio with New International CoPrimer™ Patent
-
Proactive news headlines including Co-Diagnostics, Esports Entertainment, Versus Systems and Plurilock Security
-
Proactive news headlines including Co-Diagnostics, Esports Entertainment, Versus Systems and Plurilock Security
Back to CODX Stock Lookup
